Related Experiment Videos
Effect of plasma on human erythrocyte beta-adrenergic receptors
Biochemical Pharmacology
|October 15, 1985
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Bicaudal D2 autoantibodies are highly specific for systemic sclerosis.
Scandinavian journal of rheumatology·2024
Corticosterone Contributes to Diet-Induced Reprogramming of Post-Metamorphic Behavior in Spadefoot Toads.
Integrative organismal biology (Oxford, England)·2024
Effectiveness, safety and impact of guselkumab on sexuality and perceived stigmatization in patients with psoriasis in routine clinical practice: Week 28 results from the prospective German multicentre G-EPOSS study.
Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Experience with the Ketogenic Diet in a Boy with CLCN4 Related Neurodevelopmental Disorder.
Balkan journal of medical genetics : BJMG·2024
TEAD upregulation promotes osimertinib resistance in NSCLC by recruiting YAP into the nucleus.
Biochemical pharmacology·2026
Multilayered clearance concept: a membrane-resolved flux framework for drug metabolism.
Biochemical pharmacology·2026
Acute leukemia therapy at a crossroads: from conventional chemotherapy to the era of precision medicine.
Biochemical pharmacology·2026
Allosteric kinase inhibition in hematological malignancies: from asciminib to emerging regulatory sites.
Biochemical pharmacology·2026
Connexin-43 remodeling drives atrial arrhythmias in hypothyroidism: ranolazine as a potential therapeutic strategy.
Biochemical pharmacology·2026
MANF attenuates cholestatic liver injury by altering GRP78-PERK association.
Biochemical pharmacology·2026
Tools to investigate class B1 GPCR conformational landscapes with cryo-EM and beyond.
Biochemical Society transactions·2026
[Research progress on cell surface RNA].
Sheng li xue bao : [Acta physiologica Sinica]·2026
A programmable lipid-triggered allosteric site modulates LC3 LIR receptor binding activity.
Nature communications·2026